Drug intelligence / Profile preview

(1Z)-4-(4-fluorophenyl)-2-methylidenebutan-1-imine

Development stage: Unknown
Modality: Small Molecules

Overview

(1Z)-4-(4-fluorophenyl)-2-methylidenebutan-1-imine is a small molecule compound with the chemical formula C11H12FN and a molecular weight of 177.22 g/mol. It is listed in DrugBank as an experimental drug, but there are no approved indications, clinical trials, or detailed pharmacological data available. Its mechanism of action, biological targets, and therapeutic uses have not been characterized in public databases[1].

Other names: DB08176DB-08176DB 08176

Targets

MAOB (Monoamine oxidase B)

Beyond the preview

Go deeper on (1Z)-4-(4-fluorophenyl)-2-methylidenebutan-1-imine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (1Z)-4-(4-fluorophenyl)-2-methylidenebutan-1-imine.

Explore the full profile